Literature DB >> 11881740

Superoxide dismutase and the death of motoneurons in ALS.

J S Beckman1, A G Estévez, J P Crow, L Barbeito.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a lethal disease that is characterized by the relentless death of motoneurons. Mutations to Cu-Zn superoxide dismutase (SOD), though occurring in just 2-3% of individuals with ALS, remain the only proven cause of the disease. These mutations structurally weaken SOD, which indirectly decreases its affinity for Zn. Zn-deficient SOD induces apoptosis in motoneurons through a mechanism involving peroxynitrite. Importantly, Zn-deficient wild-type SOD is just as toxic as Zn-deficient ALS mutant SOD, suggesting that the loss of Zn from wild-type SOD could be involved in the other 98% of cases of ALS. Zn-deficient SOD could therefore be an important therapeutic target in all forms of ALS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11881740     DOI: 10.1016/s0166-2236(00)01981-0

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  65 in total

1.  The rate and equilibrium constants for a multistep reaction sequence for the aggregation of superoxide dismutase in amyotrophic lateral sclerosis.

Authors:  Sagar D Khare; Michael Caplow; Nikolay V Dokholyan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-08       Impact factor: 11.205

2.  Near-infrared fluorescent sensor for in vivo copper imaging in a murine Wilson disease model.

Authors:  Tasuku Hirayama; Genevieve C Van de Bittner; Lawrence W Gray; Svetlana Lutsenko; Christopher J Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

Review 3.  Catalytic antioxidants to treat amyotropic lateral sclerosis.

Authors:  John P Crow
Journal:  Expert Opin Investig Drugs       Date:  2006-11       Impact factor: 6.206

4.  Good science shows the way. Highlight Commentary on "Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis".

Authors:  Alvaro G Estévez
Journal:  Free Radic Biol Med       Date:  2007-04-19       Impact factor: 7.376

Review 5.  The Nrf2-ARE cytoprotective pathway in astrocytes.

Authors:  Marcelo R Vargas; Jeffrey A Johnson
Journal:  Expert Rev Mol Med       Date:  2009-06-03       Impact factor: 5.600

6.  Differential sensitivity of oligodendrocytes and motor neurons to reactive nitrogen species: implications for multiple sclerosis.

Authors:  Amy Bishop; Kimberly Green Hobbs; Asuka Eguchi; Stephanie Jeffrey; Lorraine Smallwood; Cedona Pennie; James Anderson; Alvaro G Estévez
Journal:  J Neurochem       Date:  2009-01-19       Impact factor: 5.372

7.  In vivo voxel-based relaxometry in amyotrophic lateral sclerosis.

Authors:  Martina Minnerop; Karsten Specht; Jürgen Ruhlmann; Christoph Grothe; Ullrich Wüllner; Thomas Klockgether
Journal:  J Neurol       Date:  2009-02-16       Impact factor: 4.849

8.  Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis.

Authors:  Marcelo R Vargas; Delinda A Johnson; Daniel W Sirkis; Albee Messing; Jeffrey A Johnson
Journal:  J Neurosci       Date:  2008-12-10       Impact factor: 6.167

9.  A new familial amyotrophic lateral sclerosis locus on chromosome 16q12.1-16q12.2.

Authors:  Halah Abalkhail; John Mitchell; James Habgood; Richard Orrell; Jacqueline de Belleroche
Journal:  Am J Hum Genet       Date:  2003-06-26       Impact factor: 11.025

Review 10.  Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease.

Authors:  Pradip K Kamat; Anuradha Kalani; Philip Kyles; Suresh C Tyagi; Neetu Tyagi
Journal:  Cell Biochem Biophys       Date:  2014-11       Impact factor: 2.194

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.